7607 通用幹細胞*歷年利潤比率

年度/季別毛利率營業利益率稅前淨利率稅後淨利率
2025Q278.43%-131.26%-138.77%-138.77%
2024Q445.39%-406.12%-404.93%-420.72%
2024Q218.54%-643.07%-656.60%-634.25%
2023Q433.22%-362.20%-359.98%-365.83%
2023Q238.13%-299.01%-303.46%-300.66%